V
Vivanza Biosciences
VIVANZA Share Price
Healthcare1.95
as on 13 Mar 2026 at 15:15
BSE
Market Cap
₹8 Cr
PE Ratio
-49.50
ROCE
-4.31%
VIVANZA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
8
PE Ratio
-49.50
PB Ratio
1.72
Dividend Yield
-
ROE
-17.01%
ROCE
-4.31%
Book Value (₹)
1.15
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 71.21% | 73.69% | 73.36% | 73.34% | 73.42% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
VIVANZA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
530057
NSE Scrip Name
VIVANZA
ISIN
INE984E01035



